Want the U.K.'s NHS to quickly adopt new products, drugmakers? There's an office for that

Drugmakers want market access and reimbursement for their new products as fast as possible, and now, the U.K.'s National Institute for Health and Care Excellence (NICE) is setting up an office with the same goal. The Office of Market Access will advise companies producing new drugs on how to speed up their adoption by the NHS, the BMJ reports. More (sub. req.)

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.